Relative impact of HLA phenotype and CD4-CD8 ratios on the clinical expression of hemochromatosis

Hepatology

Volumn 25, Issue 2, 1997, Pages 397-402

  Porto, Graça ^a,b   Vicente, Corália ^a   Teixeira, M Anjos ^b   Martins, Olímpia ^c   Cabeda, José Manuel ^a   Lacerda, Rosa ^a   Gonçalves, Cristina ^b   Fraga, José ^d   Macedo, Guilherme ^b   Silva, Berta M ^a   Alves, Helena ^e   Justiça, Benvindo ^b   De Sousa, Maria ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^c Regional Health Administration   (Portugal)

^d HOSPITAL DE SÃO JOÃO   (Portugal)

^e Ministerio da Saude Portuguese   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA ANTIGEN; IRON;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEMOCHROMATOSIS; HLA TYPING; HUMAN; IRON OVERLOAD; IRON STORAGE; MALE; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 12644281617     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.1997.v25.pm0009021953     Document Type: Article

References (34)

1. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, Clementi M, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nature Med 1995;12:1279-1283.
2. Chakravarti A. The CD4/CD8 ratio: message in a bottle? Nature Med 1995; 12:1240-1241.
3. Reimão R, Porto G, De Sousa M. Stability of CD4/CD8 ratios in man: new correlation between CD4/CD8 profiles and iron overload in idiopathic hemochromatosis patients. C R Acad Sci Paris 1991;313:481-483.
4. Porto G, Reimão R, Gonçalves C, Vicente C, Justica B, de Sousa M. Hemochromatosis as a window into the study of the immunological system: a novel correlation between CD8+ lymphocytes and iron overload. Eur J Haematol 1994;52:283-290.
5. Adams PC, Kertesz AE, Valberg LS. Clinical presentation of hemochromatosis: a changing scene. Am J Med 1991;90:445-449.
6. Simon M, Bourel M, Genetet B, Fauchet R. Idiopathic hemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. N Engl J Med 1977;297:1017-1021.
7. Cartwright GE, Edwards CQ, Kravitz K, Skolnick M, Amos DB, Johnson A, Buskjaer L. Hereditary hemochromatosis: phenotypic expression of the disease. N Engl J Med 1979;301:175-179.
8. Yaouanq J, Perichon M, Chorney M, Pontarotti P, Le Treut A, El Kahloun A, et al. Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE). Am J Hum Genet 1994;54:252-263.
9. Jazwinska EC, Lee SC, Webb SI, Halliday JW, Powell LW: Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet 1993;53: 347-352.
10. Worwood M. Genetics of hemochromatosis. Baillières Clin Hematol 1993; 7:903-918.
11. Powell LW, Summers KM, Board PG, Axelsen E, Webb S, Halliday JW. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology 1990;98:1625-1632.
12. Nichols GM, Bacon BR. Hereditary hemochromatosis: pathogenesis and clinical features of a common disease. Am J Gastroenterol 1989;84:851-862.
13. Vicente C, Porto G, De Sousa M. Method for establishing serum ferritin reference values depending on sex and age. J Lab Clin Med 1990;116:779-784.
14. Porto G, Vicente C, Fraga J, Martins da Silva B, De Sousa M. The importance of establishing appropriate local reference values for the screening of hemochromatosis: a study of 3 different control populations and 136 hemochromatosis family members. J Lab Clin Med 1992;119:295-305.
15. Vasconcelos JC, Porto G. Quantificação da sobrecarga hepática de ferro e detecção de hepatocarcinoma por ressonância magnética: aplicação no diagnóstico e controlo do tratamento em doentes com hemocromatose. Acta Radiol Portuguesa 1994;6:41-52.
16. Haskins P, Stevens AR Jr, Finch S, Finch CA. Iron metabolism. Iron stores in man as measured by phlebotomy. J Clin Invest 1952;31:543-547.
17. Porto G, Martins da Silva B, Vicente C, De Sousa M. Idiopathic hemochromatosis in north Portugal: association with haplotype A3B7. J Clin Pathol 1989;42:667-668.
18. Steel RGD, Torrie JH. Principles and procedures of statistics. A biomedical approach. Ed 2. New York: Mc Graw-Hill, 1980:311-335.
19. De Sousa M. T lymphocytes and iron overload: novel correlation of possible significance to the biology of the immunological system. Mem Inst Oswaldo Cruz 1982;87(suppl. V):23-29.
20. Kühn LC. Molecular regulation of iron proteins. Baillières Clin Hematol 1994;7:763-785.
21. Konijn AM. Iron metabolism in inflamation. Baillières Clin Hematol 1994; 7:829-849.
22. De Sousa M, Potaznik D. Proteins of the metabolism of iron, cells of the immune system and malignancy. In: Prasad, ed. Vitamins, nutrition, and cancer (ed Prasad AS). Basel: Karger, 1984:231.
23. Potaznik D, Groshen S, Miller D, Bagin R, Bhalla R, Schwartz M, De Sousa M. Association of serum iron, serum transferrin saturation and serum ferritin with survival in acute lymphocytic leukemia. Am J Pediatr Hematol Oncol 1987;9:350-355.
24. Hann H-WL, Lange B, Stahlhut MW, McGlynn KA. Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease. Cancer 1990;66:313-316.
25. Weinberg ED. The development awareness of iron withholding defense. Perspect Biol Med 1993;36:215-221.
26. Hershko C. Control of disease by selective iron depletion: a novel therapeutic strategy utilizing iron chelators. Baillières Clin Hematol 1994;7:965-1000.
27. Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J 1989;117:1177-1188.
28. Salonen JT, Nyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastearn Finnish men. Circulation 1992;86:803-811.
29. de Sousa M, Reimão R, Lacerda R, Hugo P, Kauffman S, Ponto G. Iron overload in β2-microglobulin deficient mice. Immunol Lett 1994;39:105-111.
30. Cragg SJ, Darke C, Worwood M. HLA class I and H ferritin gene polymorphisms in normal subjects and patients with hemochromatosis. Hum Genet 1988;80:63-68.
31. Zijlstra M, Bix M, Simister NE, Loring JM, Raulet DH, Jaenisch R. β2-Microglobulin deficient mice lack CD4-CD8+ cytolitic T cells. Nature 1990; 344:742-746.
32. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in B2M, MHC class I proteins, and CD8+ T cells. Science 1990;248:1227-1420.
33. Moldawer LL, Marano MA, Wai H, Fong Y, Silen ML, Kuo G, Manogue ICR, et al. Cachectin/tumour necrosis factor alters red blood cell kinetics and induces anemia in vivo. FASEB J 1989;3:1631-1643.
34. Konijn AM, Hershko C. The anaemia of inflamation and chronic disease. In: De Sousa M, Brock J, eds. Iron in immunity, cancer and inflamation. New York: Wiley, 1989:111-143.